These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 33256676

  • 1. Effect of sodium-glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in diabetic patients with hypertension: a retrospective observational study.
    Sawamura T, Karashima S, Nagase S, Nambo H, Shimizu E, Higashitani T, Aono D, Ohbatake A, Kometani M, Demura M, Furukawa K, Takeda Y, Yoneda T.
    BMC Endocr Disord; 2020 Nov 30; 20(1):177. PubMed ID: 33256676
    [Abstract] [Full Text] [Related]

  • 2. Effect of Sodium Glucose Co-Transporter-2 Inhibition on the Aldosterone/Renin Ratio in Type 2 Diabetes Mellitus.
    Griffin TP, Islam MN, Blake L, Bell M, Griffin MD, O'Shea PM.
    Horm Metab Res; 2019 Feb 30; 51(2):91-99. PubMed ID: 30522145
    [Abstract] [Full Text] [Related]

  • 3. Effects of Ramipril on the Aldosterone/Renin Ratio and the Aldosterone/Angiotensin II Ratio in Patients With Primary Aldosteronism.
    Guo Z, Poglitsch M, Cowley D, Domenig O, McWhinney BC, Ungerer JPJ, Wolley M, Stowasser M.
    Hypertension; 2020 Aug 30; 76(2):488-496. PubMed ID: 32507039
    [Abstract] [Full Text] [Related]

  • 4. Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System.
    Puglisi S, Rossini A, Poli R, Dughera F, Pia A, Terzolo M, Reimondo G.
    Front Endocrinol (Lausanne); 2021 Aug 30; 12():738848. PubMed ID: 34745006
    [Abstract] [Full Text] [Related]

  • 5. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
    Chen SX, Du YL, Zhang J, Gong YC, Hu YR, Chu SL, He QB, Song YY, Zhu DL.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct 30; 34(10):868-72. PubMed ID: 17217708
    [Abstract] [Full Text] [Related]

  • 6. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
    Browne GA, Griffin TP, O'Shea PM, Dennedy MC.
    Clin Endocrinol (Oxf); 2016 Mar 30; 84(3):325-31. PubMed ID: 26300226
    [Abstract] [Full Text] [Related]

  • 7. Clinical relevance of dietary salt intake on aldosterone and the aldosterone-to-renin ratio as screening parameters for primary aldosteronism.
    Koch M, Aker S, Haastert B, Rump LC.
    Clin Nephrol; 2010 Sep 30; 74(3):182-9. PubMed ID: 20860902
    [Abstract] [Full Text] [Related]

  • 8. Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study.
    Rossi GP, Ceolotto G, Rossitto G, Maiolino G, Cesari M, Seccia TM.
    J Clin Endocrinol Metab; 2020 Jun 01; 105(6):. PubMed ID: 32067030
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.
    Trenkel S, Seifarth C, Schobel H, Hahn EG, Hensen J.
    Exp Clin Endocrinol Diabetes; 2002 Apr 01; 110(2):80-5. PubMed ID: 11928071
    [Abstract] [Full Text] [Related]

  • 13. Quantitative Value of Aldosterone-Renin Ratio for Detection of Aldosterone-Producing Adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) Study.
    Maiolino G, Rossitto G, Bisogni V, Cesari M, Seccia TM, Plebani M, Rossi GP, PAPY Study Investigators.
    J Am Heart Assoc; 2017 May 21; 6(5):. PubMed ID: 28529209
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL, Zeng ZP, Tong AL, Lu L, Chen S, Li M, Fu CL, Wang YH, Sun ML.
    Zhonghua Nei Ke Za Zhi; 2012 Apr 21; 51(4):294-8. PubMed ID: 22781950
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone-renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design.
    Rossitto G, Cesari M, Ceolotto G, Maiolino G, Seccia TM, Rossi GP.
    J Hum Hypertens; 2019 Feb 21; 33(2):167-171. PubMed ID: 30518805
    [Abstract] [Full Text] [Related]

  • 18. Primary aldosteronism: Aldosterone/renin ratio cut-off points.
    Eugenio Russmann ML, Delfino L, Fierro F, Santoro S, Peréz M, Caruso G, Glikman P, Gauna A, Lupi S.
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Feb 21; 66(6):361-367. PubMed ID: 30737120
    [Abstract] [Full Text] [Related]

  • 19. Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension.
    Nishizaka MK, Pratt-Ubunama M, Zaman MA, Cofield S, Calhoun DA.
    Am J Hypertens; 2005 Jun 21; 18(6):805-12. PubMed ID: 15925740
    [Abstract] [Full Text] [Related]

  • 20. A cross-sectional study of the effects of β-blocker therapy on the interpretation of the aldosterone/renin ratio: can dosing regimen predict effect?
    Griffin TP, Browne GA, Wall D, Dennedy MC, OʼShea PM.
    J Hypertens; 2016 Feb 21; 34(2):307-15. PubMed ID: 26867057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.